Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.9400 (-2.06%) ($10.9400 - $10.9400) on Tue. May. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.91% (three month average) | RSI | 64 | Latest Price | $10.9400(-2.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.455% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.455% (StdDev 4.91%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.26 | 5 Day Moving Average | $11.65(-6.09%) | 10 Day Moving Average | $11.87(-7.83%) | 20 Day Moving Average | $11.26(-2.84%) | To recent high | -19.7% | To recent low | 19% | Market Cap | $1.93b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |